This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Performance of Xpert MTB/RIF Ultra: a matter of dead or alive

Volume: 18, Issue: 1, Pages: 8 - 10
Published: Dec 5, 2017
Abstract
In our opinion, the implementation of the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) since 2010 has revolutionised molecular diagnosis of (multidrug-resistant) tuberculosis. Xpert combines early diagnosis of tuberculosis with direct detection of rifampicin resistance, but the limitations of the assay are its suboptimal sensitivity and high rate of false positivity in low-prevalence settings. To overcome these limitations, the assay was...
Paper Fields
Paper Details
Title
Performance of Xpert MTB/RIF Ultra: a matter of dead or alive
Published Date
Dec 5, 2017
Volume
18
Issue
1
Pages
8 - 10
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.